Page last updated: 2024-10-23

bumetanide and Osteosarcoma

bumetanide has been researched along with Osteosarcoma in 1 studies

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"To probe the mechanism by which intracellular ATP, Na+, and Cl- influence the activity of the NaK2Cl cotransporter, we measured bumetanide-sensitive (BS) 86Rb fluxes in the osteosarcoma cell line UMR-106-01."3.68Regulatory interaction of ATP Na+ and Cl- in the turnover cycle of the NaK2Cl cotransporter. ( Khademazad, M; Muallem, S; Whisenant, N, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Whisenant, N1
Khademazad, M1
Muallem, S1

Other Studies

1 other study available for bumetanide and Osteosarcoma

ArticleYear
Regulatory interaction of ATP Na+ and Cl- in the turnover cycle of the NaK2Cl cotransporter.
    The Journal of general physiology, 1993, Volume: 101, Issue:6

    Topics: Adenosine Triphosphate; Animals; Antimycin A; Bumetanide; Carrier Proteins; Chlorides; Deoxyglucose;

1993